N-3 omega fatty acids: a review of current knowledge

International Journal of Food Science and Technology

Volumn 45, Issue 3, 2010, Pages 417-436

  Gogus, Ugur ^a   Smith, Chris ^b  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b UNIVERSITY OF CHESTER   (United Kingdom)

Author keywords

Food; N 3 omega fatty acids; Nutrition; Polyunsaturated fatty acid; Public health and disease

Indexed keywords

ADVERSE EFFECT; ALZHEIMER'S; BENEFICIAL EFFECTS; DIETARY SUPPLEMENTS; FOOD; FOOD SUPPLEMENTS; HUMAN SERUM; INCREASING EFFECT; INFLAMMATORY DISEASE; MEDICAL TREATMENT; MULTIPLE SCLEROSIS; N-3 OMEGA FATTY ACIDS; PHYSICAL PERFORMANCE; PROTECTIVE EFFECTS; PUBLIC HEALTH AND DISEASE; REDUCING EFFECTS; SIDE EFFECT; VERY LONG-CHAIN POLYUNSATURATED FATTY ACIDS;

DISEASES; DRUG DOSAGE; DRUG INTERACTIONS; NUTRITION; POLYUNSATURATED FATTY ACIDS;

FATTY ACIDS;

EID: 77955649671     PISSN: 09505423     EISSN: 13652621     Source Type: Journal    
DOI: 10.1111/j.1365-2621.2009.02151.x     Document Type: Review

References (187)

1. Adrogue, H.J. & Madias, N.E. (2007). Sodium and potassium in the pathogenesis of hypertension. The New England Journal of Medicine, 356, 1966-1978.
2. Almeida, J.C., Perassolo, M.S., Camargo, J.L., Bragagnolo, N. & Gross, J.L. (2006). Fatty acid composition and cholesterol content of beef and chicken meat in Southern Brazil. Brazilian Journal of Pharmaceutical Sciences, 42, 109-117.
3. Antalis, C.J., Stevens, L.J., Campbell, M., Pazdro, R., Ericson, K. & Burgess, J.R. (2006). Omega-3 fatty acid status in attentiondeficit/hyperactivity disorder. Prostaglandins Leukotrienes and Essential Fatty Acids, 75, 299-308.
4. Arkhipenko, Y.V. & Sazontova, T.G. (1995). Mechanisms of the cardioprotective effect of a diet enriched with w-3 polyunsaturated fatty acids. Pathophysiology, 2, 131-140.
5. Bajpai, P. & Bajpai, P.K. (1993). Eicosapentaenoic acid (EPA) production from microorganisms: a review. Journal of Applied Biotechnology, 30, 161-183.
6. Baker, D.G., Krakauer, K.A.., Tate, G., Laposata, M. & Zurier, R.B. (2005). Suppression of human synovial cell proliferation by dihomo linolenic acid. Arthritis Rheumatism, 32, 1273-1281.
7. Bang, H.O., Dyerberg, J. & Nielsen, A. (1971). Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet, 1, 1143-1145.
8. Barbeau, M.L., Klemp, K.F., Guyton, J.R. & Rogers, K.A. (1997). Dietary fish oil. Influence on lesion regression in the porcine model of atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 688-694.
9. Barber, M.D., Ross, J.A., Voss, A.C., Tisdale, M.J. & Fearon, K.C.H. (1999). The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. British Journal of Cancer, 81, 80-86.
10. Bartoli, G.M., Palozza, P., Luberto, C., Franceschelli, P. & Piccioni, E. (1995). Dietary fish oil inhibits human erythrocyte Mg, NaKATPase. Biochemical and Biophysical Research Communications, 213, 881-887.
11. Bates, D., Cartlidge, N.E., French, J.M. et al. (1989). A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. Neurology, Neurosurgery & Psychiatry with Practical Neurology, 52, 18-22.
12. Belluzzi, A. (2001). N-3 and n-6 fatty acids for the treatment of autoimmune diseases. European Journal of Lipid Science and Technology, 103, 399-407.
13. Bhatnagar, D. & Durrington, P.N. (2003). Omega-3 fatty acids, their role in the prevention and treatment of atherosclerosis related risk factors and complications. International Journal of Clinical Practice, 57, 305-314.
14. Borek, C. (2004). Dietary antioxidants and human cancer. Integrative Cancer Therapies, 3, 333-341.
15. Braga, M., Gianotti, L., Vignali, A. & Carlo, D.V. (1998). Immunonutrition in gastric cancer surgical patients. Nutrition, 14, 831-835.
16. Bray, G.A. & Popkin, B.M. (1998). Dietary fat intake does affect obesity. American Journal of Clinical Nutrition, 68, 1157-1173.
17. Brude, L.R., Drevon, C.A., Hjerman, I. et al. (1997). Peroxidation of low density lipoprotein from combined -hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2576-2588.
18. Calder, P.C. (2003a). Long-chain n-3 fatty acids and inflammation potential application in surgical and trauma patients. Brazilian Journal of Medical and Biological Research, 36, 433-446.
19. Calder, P.C. (2003b) n3 Polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. HYPERLINK http://www.springerlink.com/content/120379/?p=9451e714fba5444cbfca715b6c613a0c&pi=0Lipids HYPERLINK http://www.springerlink.com/content/p46n32516420/?p=9451e714fba5444cbfca715b6c613a0c&pi=038, (4) 343-352.
20. Catalan, J., Moriguchi, T., Slotnick, B., Murthy, M., Greiner, R.S. & Salem, N. Jr (2002). Cognitive deficits in docosahexaenoic aciddeficient rats. Behavioral Neuroscience, 116, 1022-1031.
21. Charalabopoulos, K., Kotsalos, A., Batistatou, A. et al. (2006). Selenium in serum and neoplastic tissue in breast cancer correlation with CEA. British Journal of Cancer, 95, 674-676.
22. Chen, W.J. & Yeh, S.L. (2003). Effects of fish oil in parenteral nutrition. Nutrition, 19, 275-279.
23. Cherubini, A., Andres-Lacueva, C., Martin, A. et al. (2007). Low plasma n-3 fatty acids and dementia in older persons The InCHIANTI study. The Journal of Gerontology Series A: Biological Sciences and Medical Sciences, 62, 1120-1126.
24. Chiu, C.J., Klein, R., Milton, R.C., Gensler, G. & Taylor, A. (2009). Does eating particular diets alter the risk of age-related macular degeneration in users of the age-related eye disease. British Journal of Ophthalmology, 93, 1-6.
25. Cho, E., Hung, S., Willett, W.C. et al. (2001). Prospective study of dietary fat and the risk of age-related macular degeneration. American Journal of Clinical Nutrition, 73, 209-218.
26. Chong, E.W.-T., Kreis, A.J., Wong, T.Y., Simpson, J.A. & Guymer, R.H. (2008). Dietary w-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration. A systematic review and Meta-analysis. Archives Opthalmology, 126, 826-833.
27. Clark, L.C., Combs, G.F., Turnbull, B.W. et al. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Journal of the American Medical Association, 276, 1957-1963.
28. Clarke, L.H., Clarke, C.R. & Lippman, M. (1999). The influence of maternal diet on breast cancer risk among female offspring. Nutrition, 15, 392-401.
29. Clayton, E.H., Hanstock, T.L., Garg, M.L. & Hazell, P.L. (2007). Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents. Acta Neuropsychiatry, 19, 92-103.
30. Cleland, L.G., James, M.J. & Proudman, S.M. (2003). The role of fish oils in the treatment of rheumatoid arthritis. Drugs, 63, 845-853.
31. Cole, G.M., Ma, Q.L. & Frautschy, S.A. (2009). Omega-3 fatty acids and dementia. Prostaglandins, Leukotrenes and Essential Fatty Acids, 81, 213-221.
32. Colin, A., Reggers, J., Castronova, V. & Ansseau, M. (2003). Lipids, depression and suicide. Encephale, 29, 49-58.
33. Connor, W.E., Neuringer, M. & Lin, D.S. (1990). Dietary effects on brain fatty acid composition the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. Journal of Lipid Research, 31, 237-247.
34. Danaei, G., Ding, E.L., Mozaffarian, D. et al. (2009). Comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Medicine, 6, 4.
35. Dasgupta, S. & Bhattacharyya, D.K. (2007). Dietary effect of Eicosapentaenoic (EPA) containing soyphspholipid. Journal of Oleo Science, 56, 563-568.
36. Davidson, M.H. & Geohas, C.T. (2003). Efficacy of over the counter nutritional supplements. Current Atherosclerosis Reports, 5, 15-21.
37. Demark-Wahnefried, W., Price, D.T., Polascik, T.J. et al. (2001). Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery. Exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology, 58, 42-52.
38. Devore, E.E., Grodstein, F., van Rooij, F.J. et al. (2009). Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. American Journal of Clinical Nutrition, 90, 170-176.
39. Diwadkar-Navsariwaka, V. & Diamond, A.M. (2004). The link between selenium and chemoprevention a case for selenoproteins. Journal of Nutrition, 134, 2899-2902.
40. Dyall, S.C. & Michael-Titus, A.T. (2008). Neurological benefits of omega-3 fatty acids. Neuromolecular Medicine, 10, 219-235.
41. Eder, K. & Brandsch, C. (2002). The effects of fatty acid composition of rapeseed oil on plasma lipids and oxidative stability of lowdensity lipoproteins in cholesterol-fed hamsters. European Journal of Lipid Science & Technology, 104, 3-13.
42. Edwards, R., Peet, M., Shay, J. & Horrobin, D. (1998). Omega-3 polyunsaturated fatty acids in the diet and in the red blood cell membranes of depressed patients. Journal of Affective Disorders, 48, 149-155.
43. El-seweidy, M.M., El-swefy, S.E., Ameen, R.S. & Hashem, R.M. (2002). Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz (streptozotocin) diabetic rats. Pharmacological Research, 45, 391-398.
44. Emmanuel, C.O. & Hubbard, V.S. (1993). Essential fatty acids (EFA) Role in pancreatic hormone release and concomitant metabolic effect. The Journal of Nutritional Biochemistry, 4, 498-509.
45. Endres, S., Ghorbani, R., Kelley, V.E. et al. (1989). The effect of dietary supplementation with (n-3) polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. New England Journal of Medicine, 320, 265-271.
46. Fenton, W.S., Dickerson, F., Boronow, J., Hibbeln, J.R. & Knable, M. (2001). A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. American Journal of Psychiatry, 158, 2071-2074.
47. Field, A.E., Willett, W.C., Lissner, L. & Colditz, G.A. (2007). Dietary fat and weight gain among women in the nurses health study. Obesity, 15, 967-976.
48. Fleischhacker, W.W. (2003). New developments in the pharmacotherapy of schizophrenia. Journal of Neural Transmission Supplement, 64, 105-117.
49. Frangou, S., Lewis, M. & McCrone, P. (2006). Efficacy of ethyleicosapentaenoic acid in bipolar depression: randomized doubleblind place-controlled study. British Journal of Psychiatry, 188, 45-50.
50. Frasure-Smith, N., Lesperance, F. & Julien, P. (2004). Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biological Psychiatry, 55, 891-896.
51. Freeman, M. P. (2000). Omega-3 fatty acids in psychiatry. A review. Annual Review of Clinical Psychology, 12, 159-165.
52. Freeman, M.P., Hibbeln, J.R., Wisner, K.L. et al. (2006). Omega 3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry, 67, 1954-1967.
53. Friedman, A. & Moe, S. (2006). Review of the effects of omega-3 supplementation in dialysis patients. Clinical Journal of American Society of Nephrology, 1, 182-192.
54. Gavia, M.H., Couto, R.C., Oyama, L.M. et al. (2003). Diets rich in polyunsaturated fatty acids effect on hepatic metabolism in rats. Nutrition, 19, 144-149.
55. Geelen, A., Schouten, J.M., Kamphuis, C. et al. (2007). Fish consumption, n-3 fatty acids and colorectal cancer: a meta-analysis of prospective cohort studies. American Journal of Epidemiology, 116, 1116-1125.
56. Geppert, J., Kraft, V., Demmelmair, H. & Koletzko, B. (2006). Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial. The British Journal of Nutrition, 95, 779-786.
57. Gianotti, L., Nespoli, L., Sargenti, M. & Nespoli, A. (2003). Nutritional therapy in surgical patients: an update. Minerva Anestesiologica, 69, 275-280.
58. Gibson, R.A., Neumann, M.A. & Makrides, M. (1997). Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipids fatty acids and neural indices of exclusively breast fed infants. European Journal of Clinical Nutrition, 51, 578-584.
59. Gil, A. (2002). Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmaceuticals, 56, 388-396.
60. Gogos, A.C., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, C.N. & Kalfarentzos, F. (1998). Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for reversibly ill patients with generalized malignancy. Cancer, 82, 395-402.
61. Goldberg, R.J. & Katz, J. (2007). A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129, 210-223.
62. Gorjao, R., Azevedo-Martins, A.K., Rodrigues, H.G. et al. (2009). Comparative effects of DHA and EPA on cell function. Pharmacological Therapy, 122, 56-64.
63. Griffiths, M.A. (1998). Inflammatory bowel disease. Nutrition, 14, 788-791.
64. Hallahan, B., Hibbeln, J.R., Davis, J.M. & Garland, M.R. (2007). Omega -3 fatty acid supplementation in patients with recurrent selfharm. British Journal of Psychiatry, 190, 118-122.
65. Hamazaki, K., Homura, M., Huan, M. et al. (2005). Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers; a randomized, placebo controlled, double-blind trial. Nutrition, 21, 705-710.
66. Hardman, W.E. (2004). (n-3) fatty acids and cancer therapy. Journal of Nutrition, 134, 3427-3430.
67. Harris, W.S., Park, Y. & Isley, W.L. (2003). Cardiovascular disease and long-chain omega-3 fatty acids. Current Opinion in Lipidology, 14, 9-14.
68. Hau, M.F., Smelt, A.H.M., Bindels, A.J.G.H. et al. (1996). Effects of fish oil on oxidation resistance of VLDL in hypertriglycerdidemic patients. Atherosclerosis, Thrombosis and Vascular Biology, 16, 1197-1202.
69. Hawthorne, A.B., Daneshmend, T.K., Hawkey, C.J. et al. (1992). Treatment of ulcerative colitis with fish oil supplementation, a prospective 12 months randomized controlled trial. Gut, 33, 922-928.
70. Hayashi, N., Tashiro, T., Yamamori, H. et al. (1999). Effect of intravenous w-6 and w-3 fat emulsion on nitrogen retention and protein kinetics in burned rats. Nutrition, 15, 135-139.
71. Heine, J., Scheinichen, D., Jaeger, K., Andre, M. & Leuwer, M. (1999). Invitro influence of parenteral lipid emulsions on the respiratory burst of neutrophils. Nutrition, 15, 540-545.
72. Heininger, K.A. (2000). A unifying hypothesis of Alzheimers disease. III. Risk Factors. Human Psychopharmacology Clinical and Experimental, 15, 1-70.
73. Heuberger, R.A., Mares-Perlman, J.A., Klein, R., Klein, B.E., Millen, A.E. & Palta, M. (2001). Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Archives of Ophthalmology, 119, 1833-1838.
74. Hibbeln, J.R. (1998). Fish consumption and major depression. Lancet, 351, 1213.
75. Hibbeln, J.R. (2002). Seafood consumption, the DHA content of mothers milk and prevalence rates of postpartum depression, a cross-national, ecological analysis. Journal of Affective Disorders, 69, 15-29.
76. Hoffman, D.R., Birch, E.E., Birch, D.G. & Uauy, R.D. (1993). Effects of supplementation with omega 3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants. American Journal of Clinical Nutrition, 57, 807-812.
77. Holm, T., Andreassen, A.K., Aukrust, P. et al. (2001). Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. European Heart Journal, 22, 428-436.
78. Horrobin, D.F. (2001). Phospholipid metabolism and depression the possible roles of phospholipase A2 and coenzme A-independent transacylase. Human Psychopharmacology, 16, 45-52.
79. Horrobin, D.F., Jenkins, K., Bennett, C.N. & Christie, W.W. (2002). Eicosapentaenoic acid and arachidonic acid: colloboration and not antagonism is the key to biological understanding. Prostaglandins, Leukotrienes and Essential Fatty Acids, 66, 83-90.
80. Ikemoto, A., Ohishi, M., Sato, Y. et al. (2001). Reversibility of n-3 fatty acid deficiency-induced alterations of learning behaviour in the rat: level of n-6 fatty acids as another critical factor. Journal of Lipid Research, 42, 1655-1663.
81. Jacobs, E.T., Jiang, R., Alberts, D.S. et al. (2004). Selenium and colorectal adenomaresults of a pooled analysis. Journal of the National Cancer Institute, 96, 1669-1675.
82. Jensen, C.L. (2006). Effects of n-3 fatty acids during pregnancy and lactation. American Journal of Clinical Nutrition, 83, 1452-1457.
83. Jensen, C.L., Voigt, R.G., Prager, T.C. et al. (2005). Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. American Journal of Clinical Nutrition, 82, 125-132.
84. Joy, C.B., Mumby-Croft, R. & Joy, L.A. (2006). Polyunsaturated fatty acid supplementation for schizophrenia. The Cochrane Database of Systematic Reviews, 3, CD001257.
85. Köller, M., Senkal, M., Kemen, M., König, W., Zumtobel, V. & Muhr, G. (2003). Impact of omega 3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clinical Nutrition, 22, 59-64.
86. Kovacic, V., Sain, M. & Vukman, V. (2003). Renal dyslipidemia in patients on chronic hemodialysis. Lijecnicki Vjesnik, 125, 77-80.
87. Kramer, H.J., Stevens, J., Grimminger, F. & Seeger, W. (1996). Fish oil fatty acids and human platelets. Dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. Biochemical Pharmacology, 52, 1211-1217.
88. Kris-Etherton, P.M. & Innis, S. (2007). Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. Journal of American Dietetic Association, 107, 1599-1611.
89. Kröger, E., Verreault, R., Carmichael, P.H. et al. (2009). Omega -3 fatty acids and risk of dementiathe Canadian study of Health and Aging. American Journal of Clinical Nutrition, 90, 184-192.
90. Kromann, N. & Green, A. (1980). Epidemiologic studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950-1974. Acta Medica Scandinavica, 208, 401-406.
91. Kuhnlein, H.V., Yeboah, F., Sedgemore, M., Sedgemore, S. & Chan, H.M. (1996). Nutritional qualities of Ooligan Grease: a traditional food fat of British Columbia First Nations. Journal of Food Composition and Analysis, 9, 18-31.
92. Kusunoki, M., Tsutsumi, K., Hara, T. et al. (2003). Ethyl icosapentate (omega-3 fatty acid) causes accumulation of lipids in skeletal muscle but suppresses insulin resistance in OLETF rats. Otsuka Long-Evans Tokushima Fatty. Metabolism, 52, 30-34.
93. Lands, W.E. (1992). Biochemistry and physiology of n-3 fatty acids. FASEB Journal, 6, 2530-2536.
94. Laure, B. & Marc, B. (2006). n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. Journal of Clinical Psychopharmacology, 26, 661-665.
95. Lauritzen, L., Jorgensen, M.H., Mikkelsen, T.B. et al. (2004). Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids, 39, 195-206.
96. Leaf, A., Xiao, F.Y., Kang, X.J. & Billman, G.E. (2003). Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacological Therapy, 98, 355-377.
97. Lebeau, T. & Robert, J.M. (2003). Diatom cultivation and biotechnologically relevant products. Part II Current and putative products. Applied Microbiology and Biotechnology, 60, 624-632.
98. Lecerf, J.M. (2009). Fatty acids and cardiovascular disease. Nutrition Reviews, 67, 273-283.
99. Lee, K.W. & Lip, G.Y. H. (2003). The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. Quarterly Journal of Medicine, 96, 465-480.
100. Levy, R. & Herzberg, G.R. (1996). Effects of a meal of fish oil or corn oil on bile flow and composition in rats previously adapted to diets containing fish oil or corn oil. Nutrition Research, 16, 805-816.
101. Li, D. (2003). Omega-3 fatty acids and non-communicable diseases. Chinese Medical Journal, 116, 453-458.
102. Lichtenstein, A.H., Appel, L.J., Brands, M. et al. (2006). Diet and life style recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation, 114, 82-96.
103. Linseisen, J., Hoffmann, J., Lienhard, S., Jauch, K.W. & Wolfram, G. (2000). Antioxidant status of surgical patients receiving TPN with an n-3 fatty acid containing lipid emulsion supplemented with tocopherol. Clinical Nutrition, 19, 177-184.
104. Liu, G., Bibus, D.M., Bode, A.M., Ma, W., Holman, R.T. & Dong, Z. (2001a). Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proceedings of the National Academy of Sciences, 98, 7510-7515.
105. Liu, M., Wallin, R. & Saldeen, T. (2001b). Effect of bread containing stable fish oil on plasma phospholipid fatty acids, triglycerides, HDL-cholesterol, and malondialdehyde in subjects with hyperlipidemia. Nutrition Research, 21, 1403-1410.
106. Lox, C.D. (1990). The effects of dietary marine fish oils (omega-3 fatty acids) on coagulation profiles in men. Genetic Pharmacology, 21, 241-246.
107. Lu, G., Windsor, S.L. & Harris, W.S. (1999). Omega-3 fatty acids after lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. The Journal of Nutritional Biochemistry, 10, 151-158.
108. MacLean, C.H., Newberry, S.J., Mojica, W.A. et al. (2006). Effects of omega-3 fatty acids on cancer risk. The Journal of American Medical Association, 295, 403-415.
109. Maes, M., Stevens, W.J., Declerek, L.S. et al. (1993). Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 17, 241-255.
110. Maes, M., Verkerk, R., Vandoolaeghe, E. et al. (1997). Serotoninimmune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. European Archives of Psychiatry and Clinical Neuroscience, 247, 154-161.
111. Mannisto, S., Smith-Warner, S.A., Spiegelman, D.A. et al. (2004). Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiology Biomarkers and Prevention, 13, 40-48.
112. Mente, A., Koning, L., Shannon, H.S. & Anand, S.S. (2009). A systematic review of the evidence supporting a causal link between dietary factors and coronary heat disease. Archives of Internal Medicine, 169, 659-669.
113. Morley, R. (1998). Nutrition and cognitive development. Nutrition, 14, 752-754.
114. Moyad, M.A. (2003). The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy part I-lifestyle changes. Current Opinion in Urology, 13, 137-145.
115. Nageswari, K., Banerjee, R. & Menon, V.P. (1999). Effect of saturated, w-3 and w-6 polyunsaturated fatty acids on myocardial infarction. Journal of Nutritional Biochemistry, 10, 338-344.
116. Namiki, M. (2007). Nutraceutical functions of sesame: a review. Critical Reviews in Food Science and Nutrition, 47, 651-673.
117. Nardini, M., DAquino, M.D., Gentili, V., DiFelice, M. & Scaccini, C. (1995). Dietary fish oil enhances plasma and LDL oxidative modification in rats. Journal of Nutritional Biochemistry, 6, 474-480.
118. Nemets, H., Nemets, B., Apter, A., Bracha, Z. & Belmaker, R.H. (2006). Omega-3 treatment of childhood depression: a controlled, double blind pilot study. American Journal of Psychiatry, 163, 1098-1100.
119. Nitenberg, G. & Raynard, B. (2000). Nutritional support of the cancer patient issues and dilemmas. Critical Reviews in Oncology/Hematology, 34, 137-168.
120. Nkondjock, A., Shatenstein, B., Maisonneuve, P. & Ghadirian, P. (2003). Specific fatty acids and human colorectal cancer: an overview. Cancer Detection and Prevention, 27, 55-66.
121. O'Keefe, J.H. Jr & Harris, W.S. (2000). From inuit to implementation: Omega-3 fatty acids come of age. Mayo Clinic Proceedings, 75, 607-614.
122. O'Keefe, S.F., Proudfoot, F.G. & Ackman, R.G. (1995). Lipid oxidation in meats of omega-3 fatty acid-enriched broiler chickens. Food Research International, 28, 417-424.
123. Onwude, J.L., Lilford, R.J., Hjartardottir, H., Staines, A. & Tuffnell, D. (1995). A randomized double blind placebo controlled trial of fish oil in high risk pregnancy. British Journal of Obstetrics and Gynaecology, 102, 95-100.
124. Ouchi, M., Ikeda, T., Nakamura, K., Harino, S. & Kinoshita, S. (2002). A novel relation of fatty acid with age-related macular degeneration. Ophthalmology, 216, 363-367.
125. Peet, M., Laugharne, J.D.E., Ahluwalia, N. & Mellor, J. (1997). Fatty acid supplementation in schizophrenic patients. Schizophrenia Research, 24, 209.
126. Peet, M., Murphy, B., Shay, J. & Horrobin, D. (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry, 43, 315-319.
127. Pereira, S.L., Leonard, A.E., Huang, Y.-S., Chuang, L.-T. & Mukerji, P. (2004). Identification of two novel microalgal enzymes involved in the conversion of the omega 3-fatty acid, eicosapentaenoic acid, to docosahexaenoic acid. The Biochemical Journal, 384, 357-366.
128. Poisson, J.P. (1990). Omega-3 polyenoic acids sources, intake. Bibliotheca Nutritio et Dieta, 46, 70-86.
129. Ponnampalam, E.N., Trout, G.R., Sinclair, A.J., Egan, A.R. & Leury, B.J. (2001). Comparison of the color stability and lipid oxidative stability of fresh and vacuum packaged lamb muscle containing elevated omega-3 and omega-6 fatty acid levels from dietary manipulation. Meat Science, 58, 151-161.
130. Prasad, K. (1997). Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis, 132, 69-76.
131. Preiss, D. & Sattar, N. (2009). Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clinical Endocrinology, 70, 815-828.
132. Puiggros, C., Chacon, P., Armadans, J.I., Clapes, J. & Planas, M. (2002). Effects of oleic-rich and omega-3 rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients. Clinical Nutrition, 21, 79-87.
133. Rader, D.J. (2003). Effects of nonstatin lipid drug therapy on highdensity lipoprotein metabolism. The American Journal of Cardiology, 91(Suppl. 1), 18-23.
134. Raes, K., de Smet, S. & Demeyer, D. (2003). Effect of dietary fatty acids as incorporation of long chain polyunsaturated fatty acids and conjugated linolenic acid in lamb, beef and pork meat a review. Animal Feed Science and Technology, 113, 199-221.
135. Raitt, M.H., Connor, W.E., Morris, C. et al. (2005). Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. The Journal of American Medical Association, 293, 2884-2891.
136. Rennie, K.L., Hughes, J., Lang, R. & Jebb, S.A. (2003). Nutritional management of rheumatoid arthritis: a review of the evidence. Journal of Human Nutrition and Dietetics, 16, 97-109.
137. Retterstol, K., Stugaard, M., Gorbitz, C. & Ose, L. (1996). Results of intensive long-term treatment of familial hypercholesterolemia. The American Journal of Cardiology, 78, 1369-1374.
138. Reynolds, K., Lewis, L.B., Nolen, D.L.J., Kinney, G.L., Sathya, B. & He, J. (2003). Alcohol consumption and risk of stroke. Journal of the American Medical Association, 289, 579-588.
139. Rokka, T., Allen, K., Valaja, J. & Ryhanen, E.-L. (2002). The effect of a Camelina sativa enriched diet on the composition and sensory quality of hen eggs. Food Research International, 35, 253-256.
140. Rose, D.P. & Connolly, J.M. (1999). Omega-3 fatty acids as cancer chemopreventive agents. Pharmacology and Therapeutics, 83, 217-244.
141. Rump, P., Mensink, R.P. & Kester Dm. Hornstra, G. (2001). Essential fatty acid composition of plasma phospholipids and birth weight: a study in term neonates. American Journal of Clinical Nutrition, 73, 797-806.
142. Russo, G.L. (2009). Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochemical Pharmacology, 77, 937-946.
143. Ruxton, C.H.S., Reed, S.C., Simpson, M.J.A. & Millington, K.J. (2007). The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. Journal of Human Nutrition and Dietetics, 20, 275-285.
144. Santoli, D., Phillips, P.D., Colt, T.L. & Zurier, R.B. (1990). Suppression of interleukin-2 dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. The Journal of Clinical Investigation, 85, 424-432.
145. Sarris, J. (2009). Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. Nutrition Reviews, 67, 125-131.
146. Sarris, G.E., Mitchell, R.S., Billingham, M.E., Glasson, J.R., Cahill, P.D. & Miller, D.C. (1989). Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. The Journal of Thoracic and Cardiovascular Surgery, 97, 841-854.
147. Sauci, Fahman & Kraut. (1994). Food Composition and Nutrition Tables, 5th edn.
148. Schacky, C., Angerer, P., Kothny, W., Theisen, K. & Mudra, H. (1999). The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 130, 554-562.
149. Schoene, N.W. (2001). Beyond deficiency: new roles for vitamins. Vitamin E and w-3 fatty acids: effectors of platelet responsiveness. Nutrition, 17, 793-796.
150. Scorolli, l., Scalinci, S.Z., Limoli, P.G. et al. (2002). Photodynamic therapy for age related macular degeneration with and without antioxidants. Canadian Journal of Ophthalmology, 37, 399-404.
151. Seddon, J.M., Rosner, B., Sperduto, R.D. et al. (2001). Dietary fat and risk for advanced age-related macular degeneration. Archives of Ophthalmology, 119, 1191-1199.
152. Shoda, R., Matsueda, K., Yamato, S. & Umeda, N. (1996). Epidemiologic analysis of Crohn's disease in Japan increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. American Journal of Clinical Nutrition, 63, 741-745.
153. Simopoulos, A.P. (2002a). Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition, 21, 495-505.
154. Simopoulos, A.P. (2002b). The importance of the ratio of omega 6/omega 3 essential fatty acids. Biomedicine and Pharmacotherapy, 56, 365-379.
155. Simopoulos, A.P. (2008). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine, 233, 674-688.
156. Simopoulos, A.P., Kifer, R.R., Martin, R.E. & Barlow, S.M. (1991). Health effects of x-3 polyunsaturated fatty acids in seafoods. World Review of Nutrition and Dietetics, 66, 488-503.
157. Sirois, I., Cheung, A.M. & Ward, W.E. (2003). Biochemical bone strength and bone mass in young male and female rats fed a fish oil diet. Prostaglandines, Leukotrienes and Essential Fatty Acids, 68, 415-421.
158. Slim, R., Hammock, D.B., Toborek, M. et al. (2001). The role of Methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells. Toxicology and Applied Pharmacology, 171, 184-193.
159. Song, C., Lin, A., Bonaccorso, S. et al. (1998). The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. Journal of Affective Disorders, 49, 211-219.
160. Stenson, W.F., Cort, D., Rodgers, J. et al. (1992). Dietary supplementation with fish oil in ulcerative colitis. Annals of Internal Medicine, 116, 609-614.
161. Su, K.P., Huang, S.Y., Chiu, C.C. & Shen, W.W. (2003). Omega-3 fatty acids in major depressive disorder. A preliminary double-blind placebo-controlled trial. European Neuropsychopharmacology, 13, 267-271.
162. Suzuki, H., Park, S.J., Tamura, M. & Ando, S. (1998). Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain-stem phospholipids and synaptic membrane fluidity in adult micea comparison of sardine oil diet with palm oil diet. Mechanism of Ageing and Development, 101, 119-128.
163. Suzuki, S., Akechi, T., Kobayashi, M. et al. (2004). Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. British Journal of Cancer, 90, 787-793.
164. Sweeney, C., Freeman, J., Gee, D.L. et al. (1999). Changes in coronary heart disease risk among Japanese exchange students. Journal of American Dietetic Association, 99(Suppl. 1), A77.
165. Tapiero, H., Nguyen Ba, G., Couvreur, P. & Tew, K.D. (2002). Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomedical Pharmacotherapy, 56, 215-222.
166. Temple, J.N. (1996). Dietary fats and coronary heart disease. Biomedicine and Pharmacotherapy, 50, 261-268.
167. Temple, J.N. (2002). Nutrition and disease: challenges of research design. Nutrition, 18, 343-345.
168. Theodoratou, E., McNeil, G., Cetnarskyj, R. et al. (2007). Dietary fatty acids and colorectal cancer: a case-control study. American Journal of Epidemiology, 116, 181-195.
169. Trautwein, E.A. (2001). n-3 Fatty acids-physiological and technical aspects for their use in food. European Journal of Lipid Science and Technology, 103, 45-51.
170. Troyer, D. & Fernandes, G. (1996). Nutrition and apoptosis. Nutrition Research, 16, 1959-1987.
171. Turner, D.N., Braby, L.A., Ford, J. & Lupton, R.J. (2002). Opportunities for nutritional amelioration of radiation of radiationinduced cellular damage. Nutrition, 18, 904-912.
172. Villa, B., Calabresi, L., Chiesa, G., Rise, P., Galli, C. & Sirtori, C.R. (2002). Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmaceutical Research, 45, 475-478.
173. Wahlqvist, M.L. (1998). Nutritional pathways to coronary heart disease. Atherosclerosis, 136, 528.
174. Ward, Q.W. & Singh, A. (2005). Omega-3/6 fatty acids: alternative sources of production. Process Biochemistry, 40, 3631.
175. de Wardener, H.E., He, F.J. & MacGregor, G.A. (2004). Plasma sodium and hypertension. Kidney International, 66, 2454-2466.
176. Weber, P. & Raederstorff, D. (2000). Triglyceride lowering effect of omega-3 LC-polyunsaturated fatty acids-a review. Nutrition, Metabolism and Cardiovascular Diseases, 10, 28-37.
177. Whelan, J. & Rust, C. (2006). Innovative dietary sources of n-3 fatty acids. Annual Review of Nutrition, 26, 75-103.
178. Wijendran, V. & Hayes, K.C. (2004). Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annual Review of Nutrition, 24, 597-615.
179. Wojenski, C.M., Silver, M.J. & Walker, J. (1991). Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish. Biochimica et Biophysica Acta, 1081, 33-38.
180. Woltil, H.A., Beusekom, C.M., Okken-Beukens, M., Schaafsma, A., Muskiet, F.A.J. & Okken, A. (1999). Development of low-birthweight infants at 1months of age correlates with early intake and status of long chain polyunsaturated fatty acids. Prostaglandines, Leukotrienes and Essential Fatty Acids, 61, 235-241.
181. Wood, O.L., Spark, A. & Spark, A. (1996). Medical nutrition therapy guidelines for treating the breast cancer patient. Journal of the American Dietetic Association, 96(Suppl. 1), A35.
182. Institute of Medicine of the National Academies, 2002-2005. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Pp. 422-541. Washington DC: The National Academies Press.
183. Yahia, A.D., Madani, S., Savelli, L.J., Prost, J., Bouchenak, M. & Belleville, J. (2003). Dietary fish protein lowers blood pressure and alters tissue polyunsaturated fatty acid composition in spontaneously hypertensive rats. Nutrition, 19, 342-346.
184. Yehuda, S., Rabinovitz, S. & Mostofsky, D.I. (1999). Essential fatty acids are mediators of brain biochemistry and cognitive functions. Journal of Neuroscience Research, 56, 565-566.
185. Yehuda, S., Rabinovitz, S. & Mostofsky, D.I. (2005). Mixture of essential fatty acids lowers test anxiety. Nutritional Neuroscience, 8, 265-267.
186. Zimmerman, J. (1997). Optimal nutrition for HIV/AIDS wellness. Journal of the American Dietetic Association, 97(Suppl. 1), A18.
187. Zyriax, B.C. & Windler, E. (2000). Dietary fat in the prevention of cardiovascular disease - a review. European Journal of Lipid Science and Technology, 102, 355-365.